Michael J. Fisch, MD, MPH, FACP, FAAHPM, FASCO
Department of General Oncology, Division of Cancer Medicine
About Dr. Michael J. Fisch
Dr. Fisch is clinical professor (part-time) at the University of Texas MD Anderson Cancer Center in Houston. His faculty career at MD Anderson began in the Department of Palliative Care and Rehabilitation in 1999. He then led the MD Anderson Community Clinical Oncology Program (CCOP) Research Base and subsequently served as the founding chair of the Department of General Oncology. In the latter role, Dr. Fisch led a group of clinical faculty involved in clinical and basic research and the management of patients in community and academic settings. Since 2015, Dr. Fisch is also employed by AIM Specialty Health, a subsidiary of Anthem, Inc. In this role, he serves as Senior Medical Director of Medical Oncology Programs and Genetics and he is involved in implementing clinical solutions for health plans who are trying to promote appropriate, safe, and affordable care.
Throughout his career, Dr. Fisch has held numerous national service roles. Currently, he is a co-chair of the SWOG Symptom Control and Quality of Life Committee and a member of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC). From 2007 to 2014, he co-chaired the NCI Symptom Management and Quality of Life Committee. He also served as chair of the Eastern Cooperative Oncology Group and the American College of Radiology Imaging Network (ECOG-ACRIN) Symptom Science and Treatment Toxicity Committee, the SWOG Social Media Working Group, and the first American Society of Clinical Oncology (ASCO) Palliative Care in Oncology Symposium.
Dr. Fisch completed his undergraduate, medical school, and internal medicine training at the University of Virginia and his hematology/oncology fellowship training at Indiana University. He also received his Master’s in Public Health at Indiana University. He is board-certified in medical oncology, internal medicine, and hospice and palliative medicine, and has been honored by election to fellowship by the professional societies in each of these disciplines.
Present Title & Affiliation
Primary Appointment
Senior National Medical Director, Department of Oncology and Genetics, Division of Cancer Medicine, AIM Specialty Health Inc, Chicago, IL
Clinical Professor, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Senior National Medical Director, Department of Oncology and Genetics, AIM Specialty Health Inc, Chicago, IL
Clinical Professor, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1997 | Indiana University, Bloomington, Indiana, US, Health Education, MPH |
| 1993 | Indiana University Medical Center, Indianapolis, Indiana, US, Hematology/Oncology fellowship training, NA |
| 1990 | University of Virginia, Charlottesville, Virginia, US, Internal Medicine residency training, NA |
| 1990 | University of Virginia, Charlottesville, Virginia, US, MD |
| 1986 | University of Virginia, Charlottesville, Virginia, US, Echols Scholar, BA |
Postgraduate Training
| 1995-1997 | Clinical Fellowship, General Oncology, Health Services Research, Indiana University, Indianapolis, Indiana |
| 1993-1996 | Clinical Fellowship, Hematology/Oncology, Indiana University, Indianapolis, Indiana |
| 1990-1993 | Clinical Residency, Internal Medicine, University of Virginia, Charlottesville, Virginia |
Board Certifications
| 2003 | American Board of Hospice and Palliative Medicine |
| 1997 | Medical Oncology |
| 1993 | Internal Medicine |
Experience & Service
Academic Appointments
National Medical Director, Department of Medical Oncology and Genetics, AIM Specialty Health, Chicago, IL, 2015 - 2022
Clinical Specialist, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2019
Professor, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2015
Chair, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009 - 2015
Associate Professor, Ad-Interim Chair, Department of General Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2008 - 2009
Associate Professor, Department of Gastrointestinal (GI) Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2006 - 2008
Associate Professor (Tenure Track), Department of Gastrointestinal (GI) Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2004 - 2006
Assistant Professor (Tenure Track), Department of Palliative Care and Rehabilitation Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 1999 - 2004
Faculty Associate, University of Virginia Center for Biomedical Ethics, Charlottesville, VA, 1999 - 1999
Assistant Professor, Department of Health Evaluation Sciences, University of Virginia Health Sciences Center, Charlottesville, VA, 1997 - 1999
Assistant Professor, Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, VA, 1997 - 1999
Administrative Appointments/Responsibilities
Clinical Medical Director, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009 - 2010
Medical Director, Department of Community Clinical Oncology Program (CCOP), The University of Texas MD Anderson Cancer Center Community Clinical Oncology Program Research Base, Houston, TX, 2004 - 2015
Center Medical Director, Palliative Care & Rehabilitation Outpatient Center, UT M. D. Anderson Cancer Center, Houston, TX, 2000 - 2004
Medical Co-Director, Department of Palliative Care and Rehabilitation Medicine, UVA, Charlottesville, VA, 1998 - 1998
Other Appointments/Responsibilities
Member, Medicare Evidence Development & Coverage Advisory Committee (MEDCAC), N/A, 2016 - Present
Member, SWOG Board of Governors, N/A, 2015 - 2017
Member, SWOG Digital Engagement Committee, N/A, 2015 - Present
Co-Chair, SWOG Symptom Control and Quality of Life Committee, N/A, 2015 - Present
Co-Chair, SWOG Social Media Working Group, N/A, 2013 - 2015
Member, National Cancer Institute (NCI) National Clinical Trials Network Working Group (NCTN-WG), n/a, 2013 - 2014
Co-Chair, National Cancer Institute (NCI), Symptom Management and Quality of Life Steering Committee, n/a, 2007 - 2014
Director, The University of Texas MD Anderson Cancer Center, General Oncology Program, Houston, TX, 2007 - 2008
Member, Board of Directors, MD Anderson Physicians Network, Houston, TX, 2006 - 2012
Chair, Eastern Cooperative Oncology Group (ECOG), Symptom Management Committee, n/a, TX, 2006 - 2013
Director, U.T. M.D. Anderson Cancer Center, Community Oncology Research Base, Houston, TX, 2004 - 2015
Associate Director of Cancer Control, U.T. M.D. Anderson Cancer Center, Community Oncology Research Base, Houston, TX, 2001 - 2003
Member, National Cancer Institute (NCI), Intergroup Health-Related Quality of Life Committee, n/a, 2001 - 2007
Co-Chair, Eastern Cooperative Oncology Group (ECOG), Pain and Symptom Management Committee, n/a, 2000 - 2005
Coordinator, Grand Rounds, The University of Texas MD Anderson Cancer Center, Houston, TX, 1999 - 2001
Oncology/Hematology Therapeutics Committee, UVA, Charlottesville, VA, 1998 - 1999
Member, Eastern Cooperative Oncology Group (ECOG), Pain and Symptom Management Subcommittee, n/a, 1997 - 2000
Member, Hoosier Oncology Group, Cancer Control Committee, n/a, 1997 - 2000
Institutional Committee Activities
Member, New Patient Access Team, 2014 - 2014
Co-Chair, Patient Experience Steering Committee, 2014 - 2015
Member, Clinical Faculty Review Committee, 2013 - 2015
Member, Medical Quality Planning Committee, 2013 - 2015
Member, Division of Internal Medicine (DoIM) Division Head Search Committee, 2013 - 2014
Member, Patient Experience Steering Committee, 2012 - 2015
Member, Physician Relations Faculty Advisory Board, 2012 - 2015
Member, PROSPR Internal Advisory Committee, 2009 - 2013
Member, Credentialing Committee of the Medical Staff, 2008 - 2009
Member, Executive Billing and Compliance Committee, 2008 - 2011
Member, Graduate Medical Education Curriculum Committee, 2006 - 2008
Co-Chair, Survivorship Working Group, Community Research Committee, 2006 - 2007
Chair, Data Safety Monitoring Board, North American Brain Tumor Consortium, 2006 - 2009
Member, Hematology-Oncology Fellowship Steering Committee, 2005 - 2015
Chair, Editorial Board, Oncolog: Report to Physicians, 2005 - 2015
Honors & Awards
| 2019 | Vicente Valero LBJ Clinician Educator of the Year |
| 2014 | Honorary Fellow, MD Anderson Cancer Medicine Fellowship Program |
| 2007 | Director's Service Award, National Cancer Institute |
| 2005 | Teacher of the Year, Division of Cancer Medicine, MD Anderson Cancer Center |
| 1994 | Travel Award, Berlex Oncology Foundation |
| 1989 | Edward Kass Travel Fellowship in Infectious Diseases |
| 1986 | Algernon Sydney Sullivan Award |
| 1985 | Omicron Delta Kappa |
| 1985 | Raven Society |
| 1983 | Echols scholar |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Stearns, V, Jegede, O, Chang, VT, Skaar, TC, Berenberg, JL, Nand, R, Shafqat, A, Jacobs, NL, Luginbuhl, W, Gilman, PB, Benson, AB, Goodman, JR, Buchschacher, G, Henry, NL, Loprinzi, CL, Flynn, PJ, Mitchell, E, Fisch, MJ, Sparano, JA, Wagner, LI. A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms. Clinical Cancer Research 30(13):2709-2718, 2024. e-Pub 2024. PMID: 38640040.
- Kanter, GP, Ozluk, P, Chi, W, Fisch, MJ, Debono, D, Parikh, RB, Jacobson, M, Bekelman, JE, Devries, A. Cancer Treatment Before and After Physician-Pharmacy Integration. JAMA Network Open 7(5), 2024. e-Pub 2024. PMID: 38780938.
- Parikh, RB, Civelek, Y, Ozluk, P, Debono, D, Fisch, MJ, Sylwestrzak, G, Bekelman, JE, Schwartz, AL. Trends in Low-Value Cancer Care During the COVID-19 Pandemic. American Journal of Managed Care 30(4):186-190, 2024. e-Pub 2024. PMID: 38603533.
- Liu, Y, Mullangi, S, Debono, D, Chen, X, Pham, TT, Fisch, MJ, Gordon, AS, Hershman, D. Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid Tumors. JCO Oncology Practice 19(9):731-740, 2023. e-Pub 2023. PMID: 37384847.
- Mullangi, S, Chen, X, Pham, TT, Liu, Y, Gordon, AS, Debono, D, Fisch, MJ, Gönen, M, Hershman, D. Association of Patient, Physician, and Practice-Level Factors with Uptake of Payer-Led Oncology Clinical Pathways. JAMA Network Open 6(5), 2023. e-Pub 2023. PMID: 37159199.
- Pham, TT, Gordon, AS, Chen, X, Debono, D, Fisch, MJ. Immunotherapy in combination with chemotherapy vs. immunotherapy alone for advanced non-small cell lung cancer and programmed death ligand 1 score <50%. Cancer Treatment and Research Communications 37, 2023. e-Pub 2023. PMID: 37839181.
- Hershman DL, Unger JM, Greenlee H, Capodice J, Lew DL, Darke A, Minasian LM, Fisch MJ, Henry NL, Crew KD. Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor-Related Joint Pain: A Randomized Clinical Trial. JAMA Netw Open 5(11):e2241720, 2022. e-Pub 2022. PMID: 36367721.
- Kanter GP, Parikh RB, Fisch MJ, Debono D, Bekelman J, Xu Y, Schauder S, Sylwestrzak G, Barron JJ, Cobb R, Qato DM, Jacobson M. Trends in Medically Integrated Dispensing Among Oncology Practices. JCO Oncol Pract 18(10):e1672-e1682, 2022. e-Pub 2022. PMID: 35830621.
- Unger JM, Vaidya R, Albain KS, LeBlanc M, Minasian LM, Gotay CC, Henry NL, Fisch MJ, Lee SM, Blanke CD, Hershman DL. Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials. J Clin Oncol 40(13):JCO2102377, 2022. e-Pub 2022. PMID: 35119908.
- Gunturu KS, Pham TT, Shambhu S, Fisch MJ, Barron JJ, Debono D. Immune checkpoint inhibitors: immune-related adverse events, healthcare utilization, and costs among commercial and Medicare Advantage patients. Support Care Cancer 30(5):4019-4026, 2022. e-Pub 2022. PMID: 35064328.
- Whisenant MS, Williams LA, Mendoza T, Cleeland C, Chen TH, Fisch MJ, Shi Q. Identification of Breast Cancer Survivors With High Symptom Burden. Cancer Nurs 45(4):253-261, 2022. e-Pub 2022. PMID: 34608052.
- Henry NL, Unger JM, Till C, Crew KD, Fisch MJ, Hershman DL. Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor-Associated Musculoskeletal Symptoms. JNCI Cancer Spectr 5(6), 2021. e-Pub 2021. PMID: 34901744.
- Van Poznak CH, Unger JM, Darke AK, Moinpour C, Bagramian RA, Schubert MM, Hansen LK, Floyd JD, Dakhil SR, Lew DL, Wade JL, Fisch MJ, Henry NL, Hershman DL, Gralow J. Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer. JAMA Oncol 7(2):246-254, 2021. e-Pub 2021. PMID: 33331905.
- Stephenson JJ, Gable JC, Zincavage R, Price GL, Churchill C, Zhu E, Stenger K, Singhal M, Nepal B, Grabner M, Fisch MJ, Debono D, Geschwender AR, Cuyun Carter G. Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study. Patient Prefer Adherence 15:2417-2429, 2021. e-Pub 2021. PMID: 34764640.
- Bekelman JE, Gupta A, Fishman E, Debono D, Fisch MJ, Liu Y, Sylwestrzak G, Barron J, Navathe AS. Association Between a National Insurer's Pay-for-Performance Program for Oncology and Changes in Prescribing of Evidence-Based Cancer Drugs and Spending. J Clin Oncol 38(34):4055-4063, 2020. e-Pub 2020. PMID: 33021865.
- Shi Q, Lee JW, Wang XS, Fisch MJ, Chang VT, Wagner L, Cleeland CS. Testing Symptom Severity Thresholds and Potential Alerts for Clinical Intervention in Patients With Cancer Undergoing Chemotherapy. JCO Oncol Pract 16(9):e893-e901, 2020. e-Pub 2020. PMID: 32369412.
- Fishman E, Fisch MJ, Liu Y, Barron JJ, Nguyen A, Sylwestrzak G. Use of Optimal Evidence-Based Anticancer Drug Regimens in Physician Offices Versus Hospital Outpatient Facilities. JCO Oncol Pract 16(8):e797-e806, 2020. e-Pub 2020. PMID: 32155109.
- Wong SF, Unger JM, Wade JL, Wagner LI, Lacouture ME, Humphries KC, Moseley A, Arnold K, Velasco MR, Floyd JD, Esparaz BT, Barzi A, Lenz HJ, Koczywas M, Dakhil S, Burton GV, Fisch MJ, Henry NL, Hershman DL, Moinpour CM. A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013. J Patient Rep Outcomes 4(1):54, 2020. e-Pub 2020. PMID: 32642992.
- Bhowmik PK, Al-Karawi MKM, Killarney ST, Dizon EJ, Chang A, Kim J, Chen SL, Principe RCG, Ho A, Han H, Mandal HD, Cortez RG, Gutierrez B, Mendez K, Sharpnack L, Agra-Kooijman DM, Fisch MR, Kumar S. Thermotropic Liquid-Crystalline and Light-Emitting Properties of Bis(4-aalkoxyphenyl) Viologen Bis(triflimide) Salts. Molecules 25(10), 2020. e-Pub 2020. PMID: 32456122.
- Hunter JJ, Maunder RG, Sui D, Esplen MJ, Chaoul A, Fisch MJ, Bassett RL, Harden-Harrison MM, Lagrone L, Wong L, Baez-Diaz L, Cohen L. A randomized trial of nurse-administered behavioral interventions to manage anticipatory nausea and vomiting in chemotherapy. Cancer Med 9(5):1733-1740, 2020. e-Pub 2020. PMID: 31957269.
- Fisch MJ, Grabner M, Mytelka DS, Raval AD, Bowman L, Kern DM, Churchill C, Singer J, Wetmore S, Barron J, Eleff M. Occurrence and Characteristics of Hospitalizations During First-Line Chemotherapy Among Individuals with Metastatic Colorectal Cancer. Cancer Manag Res 12:1535-1541, 2020. e-Pub 2020. PMID: 32184658.
- Henry NL, Unger JM, Till C, Schott AF, Crew KD, Lew DL, Fisch MJ, Moinpour CM, Wade JL, Hershman DL. Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202. Cancer 125(12):2123-2129, 2019. e-Pub 2019. PMID: 30861098.
- Hwang JP, Huang D, Vierling JM, Suarez-Almazor ME, Shih YT, Chavez-MacGregor M, Duan Z, Giordano SH, Hershman DL, Fisch MJ, Cantor SB. Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy. JCO Clin Cancer Inform 3:1-12, 2019. e-Pub 2019. PMID: 30892921.
- Fishman E, Barron J, Liu Y, Gautam S, Bekelman JE, Navathe AS, Fisch MJ, Nguyen A, Sylwestrzak G. Using claims data to attribute patients with breast, lung, or colorectal cancer to prescribing oncologists. Pragmat Obs Res 10:15-22, 2019. e-Pub 2019. PMID: 31015772.
- Dizon DS, Sedrak MS, Lewis MA, Cook E, Fisch MJ, Klemp JR, Sommers J, Ciccarella A, Gralow J, Lawton W, Nichols C, Engagement Committee SD. Incorporating Digital Tools to Improve Clinical Trial Infrastructure: A White Paper From the Digital Engagement Committee of SWOG. JCO Clin Cancer Inform 2:1-8, 2018. e-Pub 2018. PMID: 30652537.
- Shen S, Unger JM, Crew KD, Till C, Greenlee H, Gralow J, Dakhil SR, Minasian LM, Wade JL, Fisch MJ, Henry NL, Hershman DL. Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927). Breast Cancer Res Treat 172(3):603-610, 2018. e-Pub 2018. PMID: 30159789.
- Hershman DL, Unger JM, Greenlee H, Capodice JL, Lew DL, Darke AK, Kengla AT, Melnik MK, Jorgensen CW, Kreisle WH, Minasian LM, Fisch MJ, Henry NL, Crew KD. Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial. JAMA 320(2):167-176, 2018. e-Pub 2018. PMID: 29998338.
- Hershman DL, Unger JM, Crew KD, Till C, Greenlee H, Minasian LM, Moinpour CM, Lew DL, Fehrenbacher L, Wade JL, Wong SF, Fisch MJ, Lynn Henry N, Albain KS. Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715). J Natl Cancer Inst 110(6):669-676, 2018. e-Pub 2018. PMID: 29361042.
- Fisch MJ, McNeill LH, Basen-Engquist KM. Helping Colorectal Cancer Survivors Benefit From Changing Lifestyle Behaviors: Implementation Science and Private Industry Collaboration to the Rescue. JAMA Oncol 4(6):777-778, 2018. e-Pub 2018. PMID: 29801068.
- Jones D, Cohen L, Rieber AG, Urbauer D, Fellman B, Fisch MJ, Nazario A. Complementary and Alternative Medicine Use in Minority and Medically Underserved Oncology Patients: Assessment and Implications. Integr Cancer Ther 17(2):371-379, 2018. e-Pub 2018. PMID: 29025275.
- Wong YN, Manola J, Hudes GR, Roth BJ, Moul JW, Barsevick AM, Scher RM, Volk MJ, Vaughn DJ, Williams SD, Fisch MJ, Cella D, Carducci MA, Wilding G. Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial. Clin Genitourin Cancer 16(2):e315-e322, 2018. e-Pub 2018. PMID: 29173976.
- Hwang JP, Lok AS, Fisch MJ, Cantor SB, Barbo A, Lin HY, Foreman JT, Vierling JM, Torres HA, Granwehr BP, Miller E, Eng C, Simon GR, Ahmed S, Ferrajoli A, Romaguera J, Suarez-Almazor ME. Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort Study. J Clin Oncol:JCO2017756387. e-Pub 2018. PMID: 29447061.
- Henry NL, Unger JM, Schott AF, Fehrenbacher L, Flynn PJ, Prow DM, Sharer CW, Burton GV, Kuzma CS, Moseley A, Lew DL, Fisch MJ, Moinpour CM, Hershman DL, Wade JL. Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202. J Clin Oncol 36(4):326-332, 2018. e-Pub 2018. PMID: 29136387.
- Agiro A, DeVries A, Malin J, Fisch MJ. Real-World Impact of a Decision Support Tool on Colony-Stimulating Factor Use and Chemotherapy-Induced Febrile Neutropenia Among Patients With Breast Cancer. J Natl Compr Canc Netw 16(2):162-169, 2018. e-Pub 2018. PMID: 29439177.
- Ritchie CS, Zhao F, Patel K, Manola J, Kvale EA, Snyder CF, Fisch MJ. Association between patients' perception of the comorbidity burden and symptoms in outpatients with common solid tumors. Cancer 123(19):3835-3842, 2017. e-Pub 2017. PMID: 28608952.
- Hwang JP, Suarez-Almazor ME, Cantor SB, Barbo A, Lin HY, Ahmed S, Chavez-MacGregor M, Donato-Santana C, Eng C, Ferrajoli A, Fisch MJ, McLaughlin P, Simon GR, Rondon G, Shpall EJ, Lok AS. Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy. Cancer 123(17):3367-3376, 2017. e-Pub 2017. PMID: 28518219.
- Elsayem AF, Fisch MJ. Neuroleptics for Delirium: More Research Is Needed. JAMA Intern Med 177(7):1053-1054, 2017. e-Pub 2017. PMID: 28672353.
- Wells QS, Veatch OJ, Fessel JP, Joon AY, Levinson RT, Mosley JD, Held EP, Lindsay CS, Shaffer CM, Weeke PE, Glazer AM, Bersell KR, Van Driest SL, Karnes JH, Blair MA, Lagrone LW, Su YR, Bowton EA, Feng Z, Ky B, Lenihan DJ, Fisch MJ, Denny JC, Roden DM. Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults. Pharmacogenet Genomics 27(7):247-254, 2017. e-Pub 2017. PMID: 28542097.
- Sedrak MS, Dizon DS, Anderson PF, Fisch MJ, Graham DL, Katz MS, Kesselheim JC, Miller RS, Thompson MA, Utengen A, Attai DJ, in Oncology CFOOSM. The emerging role of professional social media use in oncology. Future Oncol 13(15):1281-1285, 2017. e-Pub 2017. PMID: 28589770.
- Chandwani KD, Zhao F, Morrow GR, Deshields TL, Minasian LM, Manola J, Fisch MJ. Lack of Patient-Clinician Concordance in Cancer Patients: Its Relation With Patient Variables. J Pain Symptom Manage 53(6):988-998, 2017. e-Pub 2017. PMID: 28185892.
- Adeboyeje G, Agiro A, Malin J, Fisch MJ, DeVries A. Reducing Overuse of Colony-Stimulating Factors in Patients With Lung Cancer Receiving Chemotherapy: Evidence From a Decision Support-Enabled Program. J Oncol Pract 13(4):e337-e345, 2017. e-Pub 2017. PMID: 28260403.
- Rich T, Zhao F, Cruciani RA, Cella D, Manola J, Fisch MJ. Association of fatigue and depression with circulating levels of proinflammatory cytokines and epidermal growth factor receptor ligands: a correlative study of a placebo-controlled fatigue trial. Cancer Manag Res 9:1-10, 2017. e-Pub 2017. PMID: 28203105.
- Narayan HK, Wei W, Feng Z, Lenihan D, Plappert T, Englefield V, Fisch M, Ky B. Cardiac mechanics and dysfunction with anthracyclines in the community: results from the PREDICT study. Open Heart 4(1):e000524, 2017. e-Pub 2017. PMID: 28123764.
- Kern DM, Barron JJ, Wu B, Ganetsky A, Willey VJ, Quimbo RA, Fisch MJ, Singer J, Nguyen A, Mamtani R. A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims data. Pragmat Obs Res 8:149-155, 2017. e-Pub 2017. PMID: 28894396.
- Delgado-Guay MO, Rodriguez-Nunez A, De la Cruz V, Frisbee-Hume S, Williams J, Wu J, Liu D, Fisch MJ, Bruera E. Advanced cancer patients' reported wishes at the end of life: a randomized controlled trial. Support Care Cancer 24(10):4273-81, 2016. e-Pub 2016. PMID: 27165052.
- Fisch MJ, Chang VT. Intended Target of the Centers for Disease Control and Prevention Opioid Guidelines-Reply. JAMA Oncol 2(9):1243-4, 2016. e-Pub 2016. PMID: 27466756.
- Fisch MJ, Chang VT. Striving for Safe, Effective, Affordable Care for Cancer Survivors With Chronic Pain: Another Kind of Moonshot. JAMA Oncol 2(7):862-4, 2016. e-Pub 2016. PMID: 27054656.
- Attai DJ, Sedrak MS, Katz MS, Thompson MA, Anderson PF, Kesselheim JC, Fisch MJ, Graham DL, Utengen A, Johnston C, Miller RS, Dizon DS, in Oncology CFOOSM. Social media in cancer care: highlights, challenges & opportunities. Future Oncol 12(13):1549-52, 2016. e-Pub 2016. PMID: 27025657.
- Lenihan DJ, Stevens PL, Massey M, Plana JC, Araujo DM, Fanale MA, Fayad LE, Fisch MJ, Yeh ET. The Utility of Point-of-Care Biomarkers to Detect Cardiotoxicity During Anthracycline Chemotherapy: A Feasibility Study. J Card Fail 22(6):433-8, 2016. e-Pub 2016. PMID: 27079675.
- Spencer CN, Lopez G, Cohen L, Urbauer DL, Hallman DM, Fisch MJ, Parker PA. Nurse and patient characteristics predict communication about complementary and alternative medicine. Cancer 122(10):1552-9, 2016. e-Pub 2016. PMID: 26991683.
- Tevaarwerk AJ, Lee JW, Terhaar A, Sesto ME, Smith ML, Cleeland CS, Fisch MJ. Working after a metastatic cancer diagnosis: Factors affecting employment in the metastatic setting from ECOG-ACRIN's Symptom Outcomes and Practice Patterns study. Cancer 122(3):438-46, 2016. e-Pub 2016. PMID: 26687819.
- Chouhan J, Gupta R, Ensor J, Raghav K, Fogelman D, Wolff RA, Fisch M, Overman MJ. Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction. Cancer Med 5(2):239-47, 2016. e-Pub 2016. PMID: 26714799.
- Fisch MJ, Chung AE, Accordino MK. Using Technology to Improve Cancer Care: Social Media, Wearables, and Electronic Health Records. Am Soc Clin Oncol Educ Book 35:200-8, 2016. e-Pub 2016. PMID: 27249700.
- Hwang JP, Granwehr BP, Torres HA, Suarez-Almazor ME, Giordano TP, Barbo AG, Lin HY, Fisch MJ, Chiao EY. HIV Testing in Patients With Cancer at the Initiation of Therapy at a Large US Comprehensive Cancer Center. J Oncol Pract 11(5):384-90, 2015. e-Pub 2015. PMID: 26243649.
- Fisch MJ. Advance Directives: Sometimes Necessary But Rarely Sufficient. JAMA Oncol 1(5):609-10, 2015. e-Pub 2015. PMID: 26181581.
- Anderson KO, Palos GR, Mendoza TR, Cleeland CS, Liao KP, Fisch MJ, Garcia-Gonzalez A, Rieber AG, Nazario LA, Valero V, Hahn KM, Person CL, Payne R. Automated pain intervention for underserved minority women with breast cancer. Cancer 121(11):1882-90, 2015. e-Pub 2015. PMID: 25711974.
- Penas-Prado M, Hess KR, Fisch MJ, Lagrone LW, Groves MD, Levin VA, De Groot JF, Puduvalli VK, Colman H, Volas-Redd G, Giglio P, Conrad CA, Salacz ME, Floyd JD, Loghin ME, Hsu SH, Gonzalez J, Chang EL, Woo SY, Mahajan A, Aldape KD, Yung WK, Gilbert MR, Program MD, Trials Collaborative TBT. Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. Neuro Oncol 17(2):266-73, 2015. e-Pub 2015. PMID: 25239666.
- Bilen MA, Johnson MM, Mathew P, Pagliaro LC, Araujo JC, Aparicio A, Corn PG, Tannir NM, Wong FC, Fisch MJ, Logothetis CJ, Tu SM. Randomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancer. Cancer 121(1):69-76, 2015. e-Pub 2015. PMID: 25155428.
- Lewis MA, Zhao F, Jones D, Loprinzi CL, Brell J, Weiss M, Fisch MJ. Neuropathic symptoms and their risk factors in medical oncology outpatients with colorectal versus breast, lung or prostate cancer: Results from a prospective multicenter study. J Pain Symptom Manage. e-Pub 2015. PMID: 25596011.
- Oki Y, Ewer MS, Lenihan DJ, Fisch MJ, Hagemeister FB, Fanale M, Romaguera J, Pro B, Fowler N, Younes A, Astrow AB, Huang X, Kwak LW, Samaniego F, McLaughlin P, Neelapu SS, Wang M, Fayad LE, Durand JB, Alma Rodriguez M. Pegylated Liposomal Doxorubicin Replacing Conventional Doxorubicin in Standard R-CHOP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma: An Open Label, Single Arm, Phase II Trial. Clin Lymphoma Myeloma Leuk. e-Pub 2014. PMID: 25445468.
- Sanford SD, Zhao F, Salsman JM, Chang VT, Wagner LI, Fisch MJ. Symptom burden among young adults with breast or colorectal cancer. Cancer 120(15):2255-63, 2014. e-Pub 2014. PMID: 24890659.
- Trevino KM, Abbott CH, |Fisch MJ, Friedlander RJ, Duberstein PR, Prigerson HG. Patient-oncologist alliance as protection against suicidal ideation in young adults with advanced cancer. Cancer 120(15):2272-81, 2014. e-Pub 2014. PMID: 24888503.
- Kee BK, Morris JS, Slack RS, Crocenzi T, Wong L, Esparaz B, Overman M, Glover K, Jones D, Wen S, Fisch MJ. A phase II, randomized, double blind trial of calcium aluminosilicate clay versus placebo for the prevention of diarrhea in patients with metastatic colorectal cancer treated with irinotecan. Support Care Cancer. e-Pub 2014. PMID: 25160493.
- Jones D, Zhao F, Brell J, Lewis MA, Loprinzi CL, Weiss M, Fisch MJ. Neuropathic symptoms, quality of life, and clinician perception of patient care in medical oncology outpatients with colorectal, breast, lung, and prostate cancer. J Cancer Surviv. e-Pub 2014. PMID: 25023039.
- Reeve BB, Mitchell SA, Dueck AC, Basch E, Cella D, Reilly CM, Minasian LM, Denicoff AM, O'Mara AM, Fisch MJ, Chauhan C, Aaronson NK, Coens C, Bruner DW. Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst 106(7), 2014. e-Pub 2014. PMID: 25006191.
- Fisch MJ, Zhao F, Manola J, Miller AH, Pirl WF, Wagner LI. Patterns and predictors of antidepressant use in ambulatory cancer patients with common solid tumors. Psychooncology. e-Pub 2014. PMID: 24930693.
- Guo Y, Jones D, Palmer JL, Forman A, Dakhil SR, Velasco MR, Weiss M, Gilman P, Mills GM, Noga SJ, Eng C, Overman MJ, Fisch MJ. Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: A randomized, double-blind, placebo-controlled trial. Support Care Cancer 22(5):1223-31, 2014. e-Pub 2014. PMID: 24362907.
- Hwang JP, Suarez-Almazor ME, Torres HA, Palla SL, Huang DS, Fisch MJ, Lok AS. Hepatitis C virus screening in patients with cancer receiving chemotherapy. J Oncol Pract 10(3):e167-74, 2014. e-Pub 2014. PMID: 24594679.
- Jones D, Vichaya EG, Cleeland CS, Cohen L, Thekdi SM, Wang XS, Fisch MJ. Screening for depressed mood in patients with cancer using the MD Anderson symptom inventory: Investigation of a practical approach for the oncologist. J Oncol Pract 10(2):e95-102, 2014. e-Pub 2014. PMID: 24281151.
- Zhao F, Chang VT, Cleeland C, Cleary JF, Mitchell EP, Wagner LI, Fisch MJ. Determinants of pain severity changes in ambulatory cancer patients: An analysis from ECOG E2Z02. J Clin Oncol 32(4):312-9, 2014. e-Pub 2014. PMID: 24366929.
- Jones D, Zhao F, Fisch MJ, Wagner LI, Patrick-Miller LJ, Cleeland CS, Mendoza TR. The validity and utility of the MD Anderson symptom inventory in patients with prostate cancer: Evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group. Clin Genitourin Cancer 12(13):00193-6, 2014. e-Pub 2014. PMID: 24126238.
- Fisch MJ, Abbruzzese JL, Hong WK. Evaluating physician performance in oncology: Moneyball becomes impactball. J Oncol Pract. e-Pub 2014. PMID: 24443736.
- Fisch M, Zhao F, O'Mara A, Wang X, Cella D, Cleeland C. Predictors of significant worsening of patient-reported fatigue over a one-month timeframe in ambulatory patients with common solid tumors. Cancer 120(3):442-450, 2014. e-Pub 2014. PMID: 24151111.
- Hamann HA, Lee JW, Schiller JH, Horn L, Wagner LI, Chang VT, Fisch MJ. Clinician perceptions of care difficulty, quality of life, and symptom reports for lung cancer patients: An Analysis from the Symptom Outcomes and Practice Patterns (SOAPP) Study. J Thorac Oncol. e-Pub 2013. PMID: 24189514.
- Hwang JP, Fisch MJ, Lok AS, Zhang H, Vierling JM, Suarez-Almazor ME. Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center. BMC Cancer 13(1):534. e-Pub 2013. PMID: 24209764.
- Wang XS, Zhao F, Fisch MJ, O'Mara AM, Cella D, Mendoza TR, Cleeland CS. Prevalence and characteristics of moderate to severe fatigue: A multicenter study in cancer patients and survivors. Cancer. e-Pub 2013. PMID: 24436136.
- Barsevick A, Irwin M, Hinds P, Miller A, Berger A, Jacobsen P, Ancoli-Israel S, Reeve B, Mustian K, O'Mara A, Lai J, Fisch M, Cella D. Recommendation for high priority research on cancer-related fatigue in children and adults. Journal of the National Cancer Institute 105(19):1432-40, 2013. e-Pub 2013. PMID: 24047960.
- Cleeland CS, Zhao F, Chang VT, Sloan JA, O'Mara AM, Gilman PB, Weiss M, Mendoza TR, Lee JW, Fisch MJ. The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer, 2013. e-Pub 2013. PMID: 24114037.
- Parker PA, Urbauer D, Fisch MJ, Fellman B, Hough H, Miller J, Lanzotti V, Whisnant M, Weiss M, Fellenz L, Bury M, Kokx P, Finn K, Daily M, Cohen L. A multi-site, community oncology-based randomized trial of a brief educational intervention to increase communication regarding complementary and alternative medicine. Cancer, 2013. e-Pub 2013. PMID: 23824945.
- Tevaarwerk A, Lee JW, Sesto M, Buhr K, Manola J, Cleeland CS, Wagner L, Chang V, Fisch MJ. Employment outcomes in cancer survivors with common solid tumors off active therapy: analysis from the "Symptom Outcomes and Practice Patterns (SOAPP) study. Psychooncology, 2013. e-Pub 2013.
- Mendoza TR, Zhao F, Cleeland CS, Wagner LI, Patrick-Miller LJ, Fisch MJ. The validity and utility of the M.D. Anderson Symptom Inventory in Patients with Breast Cancer: Evidence from the Symptom Outcomes and Practice Patterns Data from the Eastern Cooperative Oncology Group. Clin Breast Cancer. e-Pub 2013. PMID: 23816985.
- Cruciani RA, Zhang JJ, Manola J, Cella D, Ansari B, Fisch MJ. L-carnitine supplementation for the management of fatigue in patients with cancer: An Eastern Cooperative Oncology Group phase III, randomized, double-blind, placebo-controlled trial. J Clin Oncol 30(31):3864-9, 2012. e-Pub 2012. PMID: 22987089.
- Dizon D, Graham D, Thompson M, Johnson L, Johnston C, Fisch M, Miller R. Practical guidance: The use of social media in oncology practice. J Oncol Pract 8(5):114-24, 2012. e-Pub 2012. PMID: 23277774.
- Hwang JP, Fisch MJ, Zhang H, Kallen MA, Routbort MJ, Lal L, Vierling JM, Suarez-Almazor ME. Low rates of hepatitis B virus screening at the onset of chemotherapy. J Oncol Pract 8(4):32-9, 2012. e-Pub 2012. PMID: 23180996.
- Lal LS, Zhuang A, Hung F, Feng C, Arbuckle R, Fisch MJ. Evaluation of drug interactions in patients treated with antidepressants at a tertiary care cancer center. Support Care Cancer 20(5):983-9, 2012. e-Pub 2012. PMID: 21519946.
- Fisch MJ, Lee JW, Weiss M, Wagner LI, Chang VT, Cella D, Manola JB, Minasian LM, McCaskill-Stevens W, Mendoza TR, Cleeland CS. Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol, 2012. e-Pub 2012. PMID: 22508819.
- Ritchie CS, Kvale E, Fisch MJ. Multimorbidity: an issue of growing importance for oncologists. J Oncol Pract 7(37):371-4, 2011. e-Pub 2011. PMID: 22379419.
- Fisch MJ, Lee RT. When patients choose CAM over EBM - How to negotiate treatment. Virtual Mentor(13):336-41, 2011. e-Pub 2011.
- Fainsinger RL, Nekolaichuk C, Lawlor P, Hagen N, Bercovitch M, Fisch M, Galloway L, Kaye G, Landman W, Spruyt O, Zhukovsky D, Bruera E, Hanson J. An international multicentre validation study of a pain classification system for cancer patients. Eur J Cancer 46(16):2896-904, 2010. e-Pub 2010. PMID: 20483589.
- Lu C, Lee JJ, Komaki R, Herbst RS, Feng L, Evans WK, Choy H, Desjardins P, Esparaz BT, Truong MT, Saxman S, Kelaghan J, Bleyer A, Fisch MJ. Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: A randomized phase III trial. J Natl Cancer Inst 102(12):859-65, 2010. e-Pub 2010. PMID: 20505152.
- Lal LS, Miller LA, Arbuckle R, Hung F, Feng C, Adamus A, Fisch MJ. Disparities in outpatient anti-depressant prescribing patterns and determinants of resource utilization at a tertiary care cancer center. J Support Oncol 7(6):237-244, 2009. e-Pub 2009. PMID: 20380332.
- Fisch M. Use of antidepressants for depression in patients with advanced cancer. Lancet Oncol 8(7):567-8, 2007. e-Pub 2007. PMID: 17613418.
- Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ. Chronic pain in the cancer survivor: a new frontier. Pain Med 8(2):189-98, 2007. e-Pub 2007. PMID: 17305690.
- Fisch MJ. Fatigue trials in ambulatory cancer patients:where do we begin and where could it possibly end?. J Support Oncol 4(10):519-20, 2006. e-Pub 2006. PMID: 17136868.
- Palmer JL, Fisch MJ. Association between symptom distress and survival in outpatients seen in a palliative care cancer center. J Pain Symptom Manage 29(6):565-71, 2005. e-Pub 2005. PMID: 15963865.
- Li J, Juliar B, Yiannoutsos C, Ansari R, Fox E, Fisch MJ, Einhorn LH, Sweeney CJ. Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a phase II Hoosier Oncology Group study. J Clin Oncol 23(6):1185-91, 2005. e-Pub 2005. PMID: 15718315.
- Fisch MJ, Kim HF. Use of atypical antipsychotic agents for symptom control in patients with advanced cancer. J Support Oncol 2(5):447-52, 2004. e-Pub 2004. PMID: 15524076.
- Elsayem A, Swint K, Fisch MJ, Palmer JL, Reddy S, Walker P, Zhukovsky D, Knight P, Bruera E. Palliative care inpatient service in a comprehensive cancer center: clinical and financial outcomes. J Clin Oncol 22(10):2008-14, 2004. e-Pub 2004. PMID: 15143094.
- Cohen MZ, Williams L, Knight P, Snider J, Hanzik K, Fisch MJ. Symptom masquerade: understanding the meaning of symptoms. Support Care Cancer 12(3):184-90, 2004. e-Pub 2004. PMID: 14735337.
- Bruera E, Palmer JL, Bosnjak S, Rico MA, Moyano J, Sweeney C, Strasser F, Willey J, Bertolino M, Mathias C, Spruyt O, Fisch MJ. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study. J Clin Oncol 22(1):185-92, 2004. e-Pub 2004. PMID: 14701781.
- Fisch M. Treatment of depression in cancer. J Natl Cancer Inst Monogr, 2004. e-Pub 2004.
- Fisch MJ, Titzer ML, Kristeller JL, Shen J, Loehrer PJ, Jung SH, Passik SD, Einhorn LH. Assessment of quality of life in outpatients with advanced cancer: the accuracy of clinician estimations and the relevance of spiritual well-being--a Hoosier Oncology Group Study. J Clin Oncol 21(14):2754-9, 2003. e-Pub 2003. PMID: 12860955.
- Strasser F, Fisch M, Bodurka DC, Sivesind D, Bruera E. E-motions: email for written emotional expression. J Clin Oncol 21(9 Suppl):98s-101s, 2003. e-Pub 2003. PMID: 12743210.
- Fisch MJ, Loehrer PJ, Kristeller J, Passik S, Jung SH, Shen J, Arquette MA, Brames MJ, Einhorn LH, Group HO. Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. J Clin Oncol 21(10):1937-43, 2003. e-Pub 2003. PMID: 12743146.
- Niederhuber JE, Forastiere AA, Baggstrom MQ, Balducci L, Bosserman LD, Bosworth JL, Brose M, Goldstein M, Cripe LD, Fisch M, Hortobagyi GN, Zwelling L, Gesme D, Gordon BG, Gralow J, Grunberg SM, Klimberg VS, Lessin S, Pazdur R, Pfister DG, Runowicz CD, Come SE, Schnipper LE, Schuchter LM, Sigal EV, Stovall E, Ward JH, Hansen HH, Ostroff J, Levin B, Prokhorov A. American Society of Clinical Oncology policy statement update: Tobacco control-reducing cancer incidence and saving. J Clin Oncol 21:2777-2786, 2003. e-Pub 2003.
- Schnipper LE, Atkins M, Beveridge RA, Brenner D, Bunn P, Coleman E, Comis RL, Einhorn L, Emanuel E, Fields S, Forastiere A, Gordon BG, Halberg F, Haluska F, Hortobagyi G, Kolker A, Miller LL, Norton L, Sallan S, Scherr S, Niederhuber JE, Baggstrom MQ, Balducci L, Bosserman LD, Bosworth LL, Brose M, Come SE, Cripe LD, Fisch M, Gesme D, Goldstein N, Gordon BG, Gostout B, Gralow J, Grunberg SM, Haluska FG, Hortobagyi GN, Klimberg VS, Kuzel T, Lessin LS, Pazdur R, Pfister DG, Raghavan D, Runowicz CD, Schnipper LE, Schuchter LM, Schwartz BS, Sigal EV, Stovall E, Ward JH, Zwelling LA. American Society of Clinical Oncology policy statement: Oversight of clinical research. J Clin Oncol 21:2377-2386, 2003. e-Pub 2003.
- Fisch M, Zichi Cohen M, Rutledge C, Cripe LD. Teaching patients how to improve communication with their health care providers: a unique workshop experience. J Cancer Educ 18(4):188-93, 2003. e-Pub 2003. PMID: 14766328.
- Strasser F, Fisch M, Bodurka DC, Sivesind D, Bruera E. E-motions: email for written emotional expression. J Clin Oncol 20(15):3352-5, 2002. e-Pub 2002. PMID: 12149311.
- Bruera E, Russell N, Sweeney C, Fisch M, Palmer JL. Place of death and its predictors for local patients registered at a comprehensive cancer center. J Clin Oncol 20(8):2127-2133, 2002. e-Pub 2002. PMID: 11956274.
- Santen RJ, Petroni GR, Fisch MJ, Myers CE, Theodorescu D, Cohen RB. Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma. Cancer 92(8):2095-101, 2001. e-Pub 2001. PMID: 11596025.
- Peuckmann V, Fisch M, Bruera E. Potential novel uses of thalidomide: focus on palliative care. Drugs 60:273-292, 2000. e-Pub 2000.
- Fisch M, Callahan CM, Kesterson JG, Nichols C, Tierney WM. The use of an electronic patient record system to identify advanced cancer patients and antidepressant drug use. J Palliat Med 2(4):403-409, 1999. e-Pub 1999. PMID: 15859781.
- Fisch MJ, Unverzagt FW, Hanna MS, Bledsoe P, Menke C, Cornetta C. Information preferences, reading ability, and emotional changes during outpatient informed consent for autologous transplantation. J Cancer Educ 13:71-75, 1998. e-Pub 1998.
- Fisch MJ, Howard KL, Einhorn LH, Sledge GW. Relationship between platinum-DNA adducts in leukocytes of patients with advanced germ cell cancer and survival. Clin Cancer Res 2(6):1063-6, 1996. e-Pub 1996. PMID: 9816268.
- Farr BM, Johnston BL, Cobb DK, Fisch MJ, Germanson TP, Adal KA, Anglim AM. Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study. Arch Intern Med 155(21):2336-40, 1995. e-Pub 1995. PMID: 7487259.
- Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med 115(6):428-36, 1991. e-Pub 1991. PMID: 1872491.
- Gaffey MJ, Tucker RM, Fisch MJ, Normansell DE. The seroprevalence of cytomegalovirus among Virginia State prisoners. Public Health 103(4):303-6, 1989. e-Pub 1989. PMID: 2549559.
- Flowers RH, Schwenzer KJ, Kopel RF, Fisch MJ, Tucker SI, Farr BM. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled trial. Jama 261(6):878-83, 1989. e-Pub 1989. PMID: 2492354.
- Tucker RM, Gaffey MJ, Fisch MJ, Kaiser DL, Guerrant RL, Normansell DE. Seroepidemiology of hepatitis D (delta agent) and hepatitis B among Virginia State prisoners. Clin Ther 9(6):622-8, 1987. e-Pub 1987. PMID: 3440274.
Invited Articles
- Fisch MJ. Palliative care education in Ghana: reflections on teaching in West Africa. J Support Oncol 9(4):134-5, 2011. e-Pub 2011. PMID: 21809517.
- Reddy S, Fisch M, Bruera E. Oral methadone for cancer pain: no indication of Q-T interval prolongation or Torsades de Pointes. J Pain Symptom Manage 28(4):301-303, 2004. e-Pub 2004. PMID: 15471646.
- Fisch M. Treatment of depression in cancer. J Natl Cancer Inst Monogr 32(32):105-111, 2004. e-Pub 2004. PMID: 15263050.
Manuals, Teaching Aids, Other Teaching Publications
- Fisch, Michael J. Buoyancy: A model for self-reflection about stress and burnout in oncology providers. American Society of Clinical Oncology, 2012.
- Fisch, Michael J. Mobile health applications for personal and professional use. ASCO, 2011.
Other Articles
- Anampa-Guzmán A, Freeman-Daily J, Fisch M, Lou E, Pennell NA, Painter CA, Sparacio D, Lewis MA, Karmo M, Anderson PF, Graff SL, in Oncology CFOUSM The Rise of the Expert Patient in Cancer: From Backseat Passenger to Co-navigator. JCO Oncol Pract 18(8):578-583, 2022. PMID: 35344398.
- Alvarez-Cardona JA, Zhang KW, Mitchell JD, Zaha VG, Fisch MJ, Lenihan DJ Cardiac Biomarkers During Cancer Therapy: Practical Applications for Cardio-Oncology. JACC CardioOncol 2(5):791-794, 2020. PMID: 34396295.
- Katz MS, Anderson PF, Thompson MA, Salmi L, Freeman-Daily J, Utengen A, Dizon DS, Blotner C, Cooke DT, Sparacio D, Staley AC, Fisch MJ, Young C, Attai DJ Organizing Online Health Content: Developing Hashtag Collections for Healthier Internet-Based People and Communities. JCO Clin Cancer Inform 3:1-10, 2019. PMID: 31251658.
- Attai DJ, Anderson PF, Fisch MJ, Graham DL, Katz MS, Kesselheim J, Markham MJ, Pennell NA, Sedrak MS, Thompson MA, Utengen A, Dizon DS, in Oncology CFOOSM Risks and benefits of Twitter use by hematologists/oncologists in the era of digital medicine. Semin Hematol 54(4):198-204, 2017. PMID: 29153081.
- Lenihan DJ, Hartlage G, DeCara J, Blaes A, Finet JE, Lyon AR, Cornell RF, Moslehi J, Oliveira GH, Murtagh G, Fisch M, Zeevi G, Iakobishvili Z, Witteles R, Patel A, Harrison E, Fradley M, Curigliano G, Lenneman CG, Magalhaes A, Krone R, Porter C, Parasher S, Dent S, Douglas P, Carver J Cardio-Oncology Training: A Proposal From the International Cardioncology Society and Canadian Cardiac Oncology Network for a New Multidisciplinary Specialty. J Card Fail 22(6):465-71, 2016. PMID: 27038642.
- Reyes-Gibby CC, Wu X, Spitz M, Kurzrock R, Fisch M, Bruera E, Shete S Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol 9(8):777-85, 2008. PMID: 18672213.
- Sloan JA, Berk L, Roscoe J, Fisch MJ, Shaw EG, Wyatt G, Morrow GR, Dueck AC, Institute NC Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol 25(32):5070-7, 2007. PMID: 17991923.
- Kim HF, Fisch MJ Antidepressant use in ambulatory cancer patients. Curr Oncol Rep 8(4):275-81, 2006. PMID: 17254527.
- Moynihan T, Kelly DG, Fisch MJ To feed or not to feed: is that the right question?. J Clin Oncol 23(25):6256-9, 2005. PMID: 16135494.
- Tunkel AR, Fisch MJ, Schlein A, Scheld WM Enterobacter endocarditis. Scand J Infect Dis 24(2):233-40, 1992. PMID: 1641601.
Editorials
- Fisch MJ, McNeill LH, Basen-Engquist KM. Helping colorectal cancer survivors benefit from changing lifestyle behaviors: implementation science and private industry collaboration to the rescue. JAMA Oncol 6(29801068):777-778, 2018.
- Elsyaem AF, Fisch MJ. Neuroleptics for delirium: More research is needed [letter]. JAMA Intern Med 7(28672353):177, 2017.
- Fisch MJ, Chang VT. Striving for Safe, Effective, Affordable Care for Cancer Survivors With Chronic Pain: Another Kind of Moonshot. JAMA Oncol(27054656), 2016.
- Fisch MJ. Advance directives: sometimes necessary but rarely sufficient. JAMA Oncol 5(26185151):609-610, 2015.
Abstracts
- Bekelman JE, Gupta A, Fishman E, Debono DJ, Fisch MJ, Liu Y, Sylwestrzak G, Barron J, Navathe AS. 86.Association between a national insurer’s pay-for-performance program for oncology and changes in prescribing of evidence-based cancer drugs and spending. J Clin Oncol 38(2016), 2020. e-Pub 2020.
- Radeke E, Lee JW, Patel A, Zaren H, Fisch MJ, Wagner LI. Reproductive health in cancer. ASCO Annual Meeting(TPS6649), 2019. e-Pub 2019.
- Fisch MJ, Liu Y, Nguyen A, Barron J, Fishman E, and Sylwestrzak G. The use of optimal evidence-based chemotherapy regimens in physician offices versus hospital outpatient facilities. ASCO Annual Meeting, 2019. e-Pub 2019.
- Fisch M, Liu Y, Nguyen A, Barron J, Fishman E, Sylwestrzak G. The use of optimal evidence-based chemotherapy (chemo) regimens in physician offices versus hospital outpatient facilities. J Clin Oncol 37(6514), 2019. e-Pub 2019.
- Fisch MJ, Grabner M, Mytelka DS, Raval AD, Bowman L, Kern DM, Churchill C, Singer J, Wetmore S, Barron J, Eleff M. Occurrence and characteristics of hospitalizations during first-line chemotherapy among individuals with metastatic colorectal cancer. J Clin Oncol 36(4S), 2018. e-Pub 2018.
- Fisch MJ, Grabner M, Mytelka DS, Raval AD, Bowman L, Kern DM, Churchill C, Singer J, Wetmore S, Barron J, Eleff M. Occurrence and characteristics of hospitalizations during first-line chemotherapy among individuals with metastatic colorectal cancer. J Clin Oncol 36(4S), 2018. e-Pub 2018.
- Adeboyeje G, Agiro A, DeVries A, Fisch M, Malin, JL. Reducing overuse of colony-stimulating factors without compromising patient safety: Evidence from a decision-support enabled utilization management in patients with lung cancer receiving chemotherapy. J Clin Oncol 35(8S), 2017. e-Pub 2017.
- Barron J, Kern DM, Wu B, Malin J, Ganetsky A, Wiley VJ, Quimbo RA, Fisch MJ, Singer J, Mamtani R. A validation of clinical data captured from a novel cancer care quality program directly integrated with administrative claims data. AMCP (American Managed Care and Specialty Pharmacy) Nexus 2016 Conference, National Harbor, Maryland, 2016. e-Pub 2016.
- Hwang J, Lok AS, Cantor SB, Fisch M, Barbo AG, Lin HY, Suarez-Almazor ME. Efficacy of selective screening in identifying patients with hepatitis B before cancer therapy. J Clin Oncol 34, 2016. e-Pub 2016.
- Stevens, PL, Lenihan DJ, Ky B, Warneke CL, Johnson MM, Abramson VG, Mayer IA, Adams PT, Campbell MG, Cheema PS, Moore DF, Yeshwant C, Carver JR, Fisch M. Prediction and early detection of anthracycline-related cardiotoxicity using cardiac biomarkers. J Clin Oncol 32(5s), 2014. e-Pub 2014.
- Ky B, Wameke CL, Lenihan DJ, Cheema PS, Moore DF, Campbell MG, YeshwantC, Adams PT, Krone R, Carver JR, Nasta S, Svoboda J, Schuster SJ, Reddy NM, Patel SM, Rieber AG, Johnson MM, Fisch M. Clinical risk prediction in anthracycline cardiotoxicity. J Clin Oncol 32(5s), 2014. e-Pub 2014.
- Tevaarwerk A, Lee JW, Sesto ME, Terhaar A, Smith ML, Cleeland CS, Wagner LI, Fisch M. Factors asociated with loss of employment among metastatic patients. J Clin Oncol 32(5s), 2014. e-Pub 2014.
- Tevaarwerk AJ, Lee JW, Sesto ME, Buhr KA, Cleeland CS, Manola J, Ll W, Chang VT, Fisch MJ. Employment outcomes among survivors of common cancers: the Symptom Outcomes and Practice Patterns (SOAPP) study. J Cancer Surviv 7(2):191-202, 2013. e-Pub 2013. PMID: 23378060.
- Hwang J, Suarez-Almazor M, Palla S, Huang D, Torres H, Fisch M, Lok A. Hepatitis C virus screening prior to chemotherapy. Multinational Association for the Supportive Care in Cancer, Berlin, Germany, 2013. e-Pub 2013.
- Zhao F, Chang V, Cleeland C, Cleary J, Mitchell E, Patterson E, Wagner L, Fisch M. Determinants of pain improvement in outpatient oncology according to baseline categories of pain severity. MASCC Symposium, June 28-30, 2012, New York City, NY, 2012. e-Pub 2012.
- Cohen, L, Urbauer D, Fisch M, Fellman B, Hough H, Miller J, Lanzotti V, Whisnant M, Weiss M, Fellenz L, Bury M, Kokx P, Finn K, Daily M, Parker P. A brief educational intervention to increase communication about complementary and alternative medicine (CAM) in community oncology settings. ASCO Annual Meeting, Chicago, IL, June 1-5, 2012, 2012. e-Pub 2012.
- Gilbert M, Hess K, Lagrone L, Groves M, Levin V, Groot D, J, Loghin M, Puduvalli V, Fisch M, Giglio P, Colman H, Conrad C, Aldape K, Yung WK. Randomized phase II 8-arm factorial study of adjuvant dose-dense (dd) temozolomide (TMZ) with permutations of thalidomide (Thal), isotretinoin (CRA), and/or celeboxib (Cel) for newly diagnosed glioblastoma (GBM). ASCO Annual Meeting, Chicago, IL, June 1-5, 2012 30, 2012. e-Pub 2012.
- Hwang J, Fisch M, Lok A, Zhang H, Vierling J, Suarez-Almazor, M. Trends in hepatitis B virus screening in a large U.S. cancer center. ASCO Annual Meeting, Chicago, IL, June 1-5, 2012, 2012. e-Pub 2012.
- Patrick-Miller L, Zhao F, Cleeland C, Wagner L, Fisch M, Mendoza T. Validity and utility of the MD Anderson Symptom Inventory (MDASI) among prostate cancer patients: Data from E2Z02: Symptom Outcomes and Practice Patterns (SOAPP). ASCO Annual Meeting, Chicago, IL, June 1- 5, 2012, 2012. e-Pub 2012.
- Ritchie C, Manola J, Kvale E, Snyder CF, Fisch M. The relationship between symptom burden and perceived comorbidity in outpatients with common solid tumors. ASCO Annual Meeting, Chicago, IL, June 1-5, 2012, 2012. e-Pub 2012.
- Wang X, Zhao F, Fisch M, Mendoza T, O'Mara A, Cella D, Cleeland C. Defining mild, moderate, and severe fatigue in cancer patients and survivors: E2Z02, a trial of the Eastern Cooperative Oncology Group. ASCO Annual Meeting, June 1- 5, 2012, Chicago, IL, 2012. e-Pub 2012.
- Chang V, Zhao F, Tevaarwerk A, Mitchell E, Patterson E, Ritchie C, Manola J, Wagner L, Fisch M. Understanding the patterns and determinants of change in driving status in outpatients with common solid tumors. MASCC Symposium, June 28-30, 2012, New York City, NY, 2012. e-Pub 2012.
- Hwang J, Fisch M, Zhang H, Kallen M, Routbort M, Lal L, Vierling J, Suarez-Almazor M. Low Rates of Hepatitis B Virus Screening at the Onset of Chemotherapy. Journal of Oncology Practice 8(4):32-9, 2012. e-Pub 2012. PMID: 23180996.
- Manola J, Zhao F, Miller A, Pirl W, Wagner L, Fisch M. Patterns of antidepressant use in cancer patients (pts): An analysis from SOAPP (ECOG E2Z02): Symptom Outcomes and Practice Patterns). ASCO Annual Meeting, June 1- 5, 2012, Chicago, IL, 2012. e-Pub 2012.
- Fisch M, Zhao F, O'Mara A, Wang X, Cella D, Cleeland C. Determinants of fatigue improvement in outpatient oncology according to baseline categories of fatigue severity. ASCO Annual Meeting, June 1- 5, 2012, Chicago, IL, 2012. e-Pub 2012.
- Grunberg S, Munsell M, Morrow P, Giguere J, Ule U, Saccaro S, Onitilo A, Metzner-Sadurski J, Fisch M. Randomized double-blind evaluation of dronabionol for the prevention of chemotherapy-induced nausea. ASCO Annual Meeting, Chicago, IL, June 1-5, 2012, 2012. e-Pub 2012.
- Mendoza, T, Zhao F, Cleeland C, Wagner L, Patrick-Miller L, Fisch M. Understanding the symptom experience of breast cancer outpatients: The validity and utility of the MD Anderson Symptom Inventory (MDASI). ASCO Annual Meeting, Chicago, IL, June 1- 5, 2012, 2012. e-Pub 2012.
- Zhao F, Wagner L, Pirl W, Miller A, Fisch M. Racial disparities in depressive symptom prevalence and selective serotonin reuptake inhibitor (SSRI) utilization in cancer patients: An analysis from ECOG E2Z02: Symptom Outcomes and Practice Patterns (SOAPP). ASCO Annual Meeting, June 1- 5, 2012, Chicago, IL, 2012. e-Pub 2012.
- Harden-Harrison M, Munsell MF, Fisch MJ, Ule UJ, Saccaro S, Onitilo A, Metzner-Sadurski JK, Giguere JK, Grunberg SM. Randomized double-blind evaluation of dronabinol in prevention of chemotherapy induced nausea. Multinational Association of Supportive Cancer Care (MASCC) Annual Meeting, New York, NY, 2012. e-Pub 2012.
- Fisch M. Disparities in cancer palliative care for medically underserved populations. American Association for Cancer Research (AACR) Annual Meeting, San Diego, CA, 2012. e-Pub 2012.
- Wagner L, Zicki L, Smith M, Cella D, Coles C, Patrick-Miller L, Manola J, Fisch M. Prospective assessment of symptom burden among cancer survivors with common solid tumors: Results from ECOG trial E2Z02. American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, IL, 2011. e-Pub 2011.
- Reyes-Gibby C, Rieber A, Merriman K, Hahn K, Fisch M. Symptoms at initial presentation of cancer patietns in a tertiary public hospital in the United States: variations by race, ethnicity, and/or language preference. Congreso Latinamericano de Cuidados Paliativos, Curitiba, Brazil, 2011. e-Pub 2011.
- Hwang J, Fisch M, Zhang H, Kallen M, Routbort M, Lal S, Vierling J, Suarez-Almazor M. Reactivation of hepatitis B infection among pateints with cancer. American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, IL, 2011. e-Pub 2011.
- Chang V, Zhao F, Wagner I, Sanford D, Salsman J, Fisch M. Symptom burden and change among adolescent/young adult (AYA) patients withi breast, lung, colorectal, or prostate cancer. American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, IL, 2011. e-Pub 2011.
- Hwang J, Fisch M, Zhang H, Kallen A, Routbort M, Lal L, Vierling J, Suarez-Almazor M. Predictors of hepatitis B screening among patients with cancer. Gastrointestinal Cancers Symposium, San Francisco, CA, 2011. e-Pub 2011.
- Fisch M, Lee J, Chang VT, Wagner LI, Cella D, Minasian LM, McCaskill-Stevens, M Weiss WJ, Smith M, Cleeland CS. A prospective evaluation of symptom change over 4 weeks for outpatients with common solid tumors: Results from E2Z02 (the SOAPP study). J Clin Oncol 28(15). e-Pub 2010.
- Hamann HA, Lee J, Schiller JH, Horn L, Cleeland CS, Manola J, Wagner LI, Chang VT, FischMF. Clinician perceptions of care difficulty and quality of life for lung cancer patients: Results from the ECOG SOAPP study (E2Z02). J Clin Oncol 28(15), 2010. e-Pub 2010.
- Elsayem AF, Bain KT, Palmer JL, Bearden J, Fisch M. A randomized comparison of oral methadone as a "first-switch" opioid versus opioid switching between sustained-release morphine and oxycodone for oncology outpatients with pain management problems. J Clin Oncol 28(15s), 2010. e-Pub 2010.
- Parker PA, Cohen L, Bekele BN, Hough H, Lee RT, Fisch M. Complementary and alternative medicine (CAM) use among cancer patients in community oncology settings. J Clin Oncol 28, 2010. e-Pub 2010.
- Tevaarwerk J Lee M Sesto C, Buhr KA, Cleeland CS, Manola J, Wagner LI, Chang VT, Fisch M. Predictors of employment (empl) outcomes in outpatients (pts) with common solid tumors: A secondary analysis from E2Z02 (ECOG's SOAPP study). J Clin Oncol 28(15s), 2010. e-Pub 2010.
- Chang V, Lee JW, Wagner L, Weiss M, Cleeland C, Fisch M. A Prospective Evaluation of Functional Change over 4 weeks for outpatients with common solid tumors: results from ECOG E2Z02 (The SOAPP study). Support Care Cancer 18(3):16-166, 2010. e-Pub 2010.
- Hwang J, Fisch M, Zhang H, Kallen MA, Routbort M, Lal L, Vierling J, Suarez-Almazor M. Hepatitis B screening and positivity prior to chemotherapy. J Clin Oncol 28, 2010. e-Pub 2010.
- Cruciani RA, Zhang J, Manola JB, Cella D, Ansari B, Fisch MJ. Phase III randomized, placebo-controlled trial of L-carnitine supplementation for fatigue in patients with cancer. J Clin Oncol 27. e-Pub 2009.
- Rich TA, Fisch MJ, Manola J, Cella D, Ansari B, Koc M, Cruciani R. Analysis of cytokines in ECOG E4Z02: A phase III randomized study of l-carnitine supplementation for fatigue in patients with cancer. J Clin Oncol 27(15), 2009. e-Pub 2009.
- Rodriguez MA, Wei W, Huang X, Fisch M, Durand JB. Evaluation of brain natriuretic peptide (BNP), troponin levels, and left ventricular ejection fraction (LVEF) in older adults with diffuse large B cell lymphoma (DLBCL). J Clin Oncol 27(15). e-Pub 2009.
- Lu C, Komaki R, Herbst RS, Evans WK, Lee JJ, Truong M, Moore CA, Choy H, Bleyer A, Fisch MJ. A phase III study of AE-941 with induction chemotherapy and concomitant chemoradiotherapy for state III non-small cell lung cancer. Proc Am Soc Clin Oncol 24, 2005. e-Pub 2005.
- Xiong HQ, Hess KR, Kayaleh OR, Goodwin JW, Banerjee T, Sinclair SS, Fisch MJ, Wolff RA, Abbruzzese JL. A phase II trial of gemcitabine and celecoxib for metastatic pancreatic cancer. Proc Am Soc Clin Oncol 24, 2005. e-Pub 2005.
- Fisch MJ, Sherman LK, Adamus AT, Hung FC, Shen LF, Lange GO, Palmer JL. Trends in antidepressant prescribing at a comprehensive cancer center. Proc Am Soc Clin Oncol 23:549, 2004. e-Pub 2004.
- Esphani N, Fisch MJ. Opioid pseudo-addiction versus addiction in chronic use to control diarrhea in cancer patients. American Pain Society Scientific Meeting, Chicago, IL, 2003. e-Pub 2003.
- Cohen MZ, Williams L, Fisch MJ. The relationship between symptom meaning and symptom expression: the perspective of advanced cancer patients and their caregivers. 7th National Cancer Nursing Research Conference, San Diego, CA, 2003. e-Pub 2003.
- Cohen MZ, Williams L, Fisch MJ. Symptom masquarade: Understanding the meaning of symptoms. Southern Nursing Research Society, Orlando, Florida, 2003. e-Pub 2003.
- Esphani N, Palmer JL, Shen L, Lange GO, Bruera E, Fisch MJ. Patterns of outpatient opioid prescribing at a comprehensive cancer center: The dramatic increase in methadone prescribing for cancer pain over a 3-year period. Proc Am Soc Clin Oncol 22:790, 2003. e-Pub 2003.
- Zhukovsky DS, Palmer JL, Elsayem A, Esphani N, Lange GO, Shen L, Bruera E, Fisch MJ. Racial differences in health services utilization in patients receiving opioids for cancer pain. Proc Am Soc Clin Oncol 22:555, 2003. e-Pub 2003.
- Li J, Juliar B, Ansari R, Fox E, Fisch M, Einhorn LH, Sweeney C. A Hoosier Oncology Group phase II study of weekly paclitaxel and gemcitabine in advanced transitional cell carcinoma of the urothelium. Proc Am Soc Clin Oncol 22:408, 2003. e-Pub 2003.
- Fisch MJ, Strasser F, Driver L, Burton A, Palmer JL, Shen L, Willey J, Bruera E. The effect of donepezil on sedation and fatigue in patients receiving opioids for cancer pain: A pilot study. Proc Am Soc Clin Oncol 22:750, 2003. e-Pub 2003.
- Palmer JL, Shen L, Bruera E, Fisch MJ. Association between symptom distress and survival in outpatients with cancer seen in a palliative care center. Proc Am Soc Clin Oncol 22:753, 2003. e-Pub 2003.
- Reddy S, Bruera E, Willey J, Burkett A, Fisch M. Oral methadone for cancer pain: no indication of Q-T interval prolongation or torsades de pointes. Proc Am Soc Clin Oncol 22:779, 2003. e-Pub 2003.
- Fisch MJ, Palmer JL, Zhukovsky DS, Walker PW, Bruera EB. Screening for depressive symptoms in cancer outpatients: association between a numerical rating scale (NRS) and a two-question screening survey (TQSS). Proc Annu Meet Am Soc Clin Oncol 21:375a, 2002. e-Pub 2002.
- Strasser F, Fisch M, Bruera E. Characterization of palliative care syndromes: a pilot study catching a clinical reality. 2nd Congress of Research in Palliative Care, Lyon, May 23-25, 2002. e-Pub 2002.
- Wagner LI, Rue M, Fisch M, Cleeland C, Bonomi PD, Schiller JH, Mehta M, Petereit D, Devore RF, Johnson DH, Cella D. Neuropsychiatric symptoms during cancer treatment: An examination of quality of life data from two ECOG lung cancer trials. Proc Annu Meet Am Soc Clin Oncol 21:357a, 2002. e-Pub 2002.
- Zhukovsky DS, Fisch MJ, Palmer JL, Shen L, Bruera E. Association of symptom intensity, opioid, and other psychoactive medication use with disease status in cancer patients treated at a Symptom Control and Palliative Care (SCPC) clinic. MASCC/ISOO 14th International Symposium, June 23-26, 2002. e-Pub 2002.
- Palmer JL, Sweeney C, Fisch MJ. Factor analysis of the Anderson Symptom Assessment System. Proc Annu Meet Am Soc Clin Oncol 21:380a, 2002. e-Pub 2002.
- Zhukovsky DS, Palmer JL, Fisch MJ, Shen L, Bruera EB. Sensation of well-being in cancer patients seen at a symptom control and palliative care clinic (SCPC) and associated clinical factors. Proc Annu Meet Am Soc Clin Oncol 21:381a, 2002. e-Pub 2002.
- McCormick BY, Fisch MJ, Ponder B. Methadone use in the hospice setting: safe, effective, and cost efficient. 20th Annual Convention of the Texas New Mexico Hospice Organization, Houston, TX, April 5-7, 2002. e-Pub 2002.
- Fisch MJ, Loehrer PJ, Passik SD, Kristellar JL, Jung S, Einhorn LH. Fluoxetine versus placebo in advanced cancer outpatients: a placebo-controlled, double-masked trial of the Hoosier Oncology Group. Proc Annu Meet Am Soc Clin Oncol 20, 2001. e-Pub 2001.
- Titzer ML, Fisch M, Kristellar JL, Jung S, Loehrer PJ, Einhorn LH. Clinicians’ assessment of quality of life in outpatients with advanced cancer: How accurate is our prediction? A Hoosier Oncology Group Study. Proc Annu Meet Am Soc Clin Oncol 20, 2001. e-Pub 2001.
- Palmer J, Fisch MJ, Warden S. Is the stability of patient self-rating of the Anderson Symptom Assessment items related to whether or not the item is the highest rated?. Proc Annu Meet Am Soc Clin Oncol 20, 2001. e-Pub 2001.
- Parmameswaran R, Fisch MJ, Ansari RH, Fox EP, Sweeney CJ, Einhorn LH. A Hoosier Oncology Group phase II study of weekly paclitaxel and gemcitabine in advanced transitional cell carcinoma of the bladder. Proc Annu Meet Am Soc Clin Oncol 20, 2001. e-Pub 2001.
- Zhukovsky DS, Fisch MJ, Warden S, Palmer L. The impact of disease extent on symptom profile, psychoactive medication use and health care utilization in cancer outpatients. J Pain 2, 2001. e-Pub 2001.
- Fisch MJ, McClain RM, Jain, K. Screening outpatients for depression: A comparison of a Two-Question Screening Survey (TQSS) and the Zung Self-Rating Depression Scale (ZSDS). Proc Annu Meet Am Soc Clin Oncol 19, 2000. e-Pub 2000.
- Fisch MJ, Marx RM, Brames MJ, Einhorn LH. Use of a two-question screening survey for depression in outpatients with advanced cancer. Proc Annu Meet Am Soc Clin Oncol 18, 1999. e-Pub 1999.
- Fisch MJ, Callahan C, Kesterson J, Nichols C, Lazaridis E, Tierney W. The use of an electronic medical record to identify advanced cancer patients and antidepressant drug use. Proc ASCO 17, 1998. e-Pub 1998.
- Fisch MJ, Unverzagt FW, Adams JA, Menke C, et al. Informed consent in adult autologous bone marrow transplant candidates: information preferences, reading ability, and affects balance. Proc ASCO 15:510, 1996. e-Pub 1996.
- Farr BM, Cobb DK, Johnston BL, Tucker SI, Germanson T, Fisch MJ. A case-controlled study of pneumococcal vaccine efficacy in preventing pneumococcal bacteremia. Interscience Conference on Antimicrobial Agents and Chemotherapy, Houston, Texas, September 18, 1989. e-Pub 1989.
Book Chapters
- Lee RT, Fisch MJ. Translating clinical research into practice for symptomatic patients. In: Cancer Symptom Science. Cambridge Unversity Press, 2011.
- Eisen T, Masterson J, Tannir N, Fisch M. Palliative Interventions. In: Renal Cancer. Cambridge University Press, 2010.
- Patel S, Fisch MJ. Palliative systemic antineoplastic therapy. In: Cancer Pain: Assessment and Management, 2nd Edition. Bruera E, Portenoy RK. Cambridge University Press, 399-419, 2010.
- Fisch MJ. Fatigue. In: Supportive Care in Cancer Therapy. Humana Press, 87-107, 2009.
- Ramondetta LJ, Fields MM, Fisch MJ. Supportive Care. In: Ovarian Cancer. Remedica, 185-225, 2009.
- Javle M, Fisch M. Overview of palliative management of pancreatic cancer. In: Handbook of Pancreatic Cancer. Springer, 2009.
- Fisch MJ. of Pain Management Principles in Specific Cancer Care Settings. In: Cancer Pain Management. McGraw-Hill, 47-56, 2007.
- Fisch MJ, Cleeland CS. Managing Cancer Pain. In: Handbook of Cancer Chemotherapy, 7th Edition. Lippincott Williams & Wilkins, 716-737, 2007.
- Fisch MJ, Swint K. Principles of Palliative Care. In: M.D. Anderson Manual of Clinical Oncology. McGraw-Hill, 1045-1056, 2006.
- Fisch MJ. Depression/Anxiety. In: Textbook of Palliative Medicine. Hodder-Arnold, 675-687, 2006.
- Fisch MJ, Swint K. Principles of Palliative Care. In: M.D. Anderson Manual of Clinical Oncology. McGraw-Hill, 2005.
- Sherman LK, Fisch MJ. Cancer and Mood Disorders. In: Psychiatry Highlights 2002-2003. Health Press, 80-87, 2004.
- Elsayem A, MJ F. Chronic Nausea. In: Cambridge Handbook of Advanced Cancer Care. Cambridge University Press, 491-499, 2003.
- Fisch MJ. Depression and Anxiety. In: Cambridge Handbook of Advanced Cancer Care. Cambridge University Press, 382-389, 2003.
- Fisch MJ. Principles of Palliative Chemotherapy. In: Cambridge Handbook of Advanced Cancer Care. Cambridge University Press, 12-21, 2003.
- Fisch MJ, Cleeland CS. Managing Cancer Pain. In: Handbook of Cancer Chemotherapy. Lippincott Williams & Wilkins, 650-673, 2003.
- Fisch MJ. Palliative Chemotherapy. In: Cancer Pain. Cambridge University Press, 311-327, 2003.
Books (edited and written)
- Cleeland CS, Fisch MJ, Dunn AJ. Cancer Symptom Science: Measurements, Mechanisms, and Management. Cambridge University Press, 2011.
- Loitman JE, Sinclair CT, Fisch MJ. Palliative Care: A Case-Based Guide. Springer, 2010.
- Fisch MJ, Burton AB. Cancer Pain Management. McGraw-Hill, 2007.
- Fisch MJ, Bruera E. Cambridge Handbook of Advanced Cancer Care. Cambridge University Press, 2003.
Letters to the Editor
- Fisch MJ, Chang VT. Intended target of the Centers for Disease Control and Prevention Opioid Guidelines. JAMA Oncol, 2016.
- Fisch MJ, Kristellear JL, Passik S, Loehrer PJ, Einhorn LH. In reply. J Clin Oncol 22: 206-208, 2004.
Selected Presentations & Talks
Local Presentations
- 2014. At the crossroads: Palliative care, oncology and the patient experience. Conference. MD Anderson Cancer Center. Houston, TX, US.
- 2014. Pearls from the lens of an academic general oncologist. Conference. MD Anderson Cancer Center. Houston, TX, US.
- 2002. Palliative care: Pearls and paradigms. Conference. UT M. D. Anderson Cancer Center. Houston, TX, US.
- 2002. Palliative care: Pearls and paradigms. Conference. UT M. D. Anderson Cancer Center. Houston, TX, US.
- 2001. Treatment of nausea and vomiting. Conference. UT M. D. Anderson Cancer Center. Houston, TX, US.
- 2001. Integrating palliative care and cancer care: Clinical issues and new paradigms. Conference. UT M. D. Anderson Cancer Center. Houston, TX, US.
- 2000. Challenges in the design, implementation, and analysis of placebo-controlled trials with subjective endpoints for outpatients with advanced cancer. Conference. UT M. D. Anderson Cancer Center. Houston, TX, US.
- 2000. Hospice care. Conference. UT M. D. Anderson Cancer Center. Houston, TX, US.
- 2000. And in addition to opoids. Conference. UT M. D. Anderson Cancer Center. Houston, TX, US.
- 2000. Depressive symptoms in outpatients with advanced cancer. Conference. UT M. D. Anderson Cancer Center. Houston, TX, US.
- 1999. Introduction to symptom control and palliative care. Conference. UT M. D. Anderson Cancer Center. Houston, TX, US.
- 1999. Prognostication in advanced cancer. Conference. UT M. D. Anderson Cancer Center. Houston, TX, US.
- 1999. Outcomes research in palliative care. Conference. UT M. D. Anderson Cancer Center. Houston, TX, US.
- 1999. Introduction to symptom control and palliative care. Conference. UT M. D. Anderson Cancer Center. Houston, TX, US.
Regional Presentations
- 2010. Community participation in clinical research: The MD Anderson model; pain management - state of the art. Conference. Northern New England Clinical Oncology Society. Stowe, VT, US.
- 2010. Hypertension and cardiac issues from the perspective of the practitioner. Conference. Reed Medical Education. Nashville, TN, US.
- 2010. Sympton responsiveness in outpatient oncology: ECOG data. Conference. Elsevier/Global Academy for Medical Education, LLC. Chicago, IL, US.
- 2010. Cultural competencies. Conference. Reed Medical Oncology. Las Vegas, NV, US.
- 2010. Cancer 101. Conference. MD Anderson Cancer Center, TX, US.
- 2010. Patient and survivor care. Conference. ASCO. San Francisco, CA, US.
- 2010. Return on relationship. Conference. American Association of Physicians Liason. Denver, CO, US.
- 2010. NCI symptom management and quality of life clinical trials planning meeting. Conference. NCI. Arlington, VA, US.
- 2010. Survey of disease and treatment-related symptoms in outpatients with invasive cancer of the breast, lung, or colon/rectum. Conference. SOAPP. Bethesda, MD, US.
- 2009. Cancer survival from the patient's perspective. Conference. Society for Integrative Oncology. New York City, NY, US.
- 2009. Become and EPEC and EPEC-O trainer. Conference. EPEC. Chicago, IL, US.
- 2009. Goals of care/advanced care planning/depression/withholding and withdrawing. Conference. EPEC and EPEC-O. Chicago, IL, US.
- 2009. Treatment trials with QOL endpoints. Conference. SxQOL. Bethesda, MD, US.
- 2009. Cancer-related pain. Conference. Meniscus Educational Institute and Elsevier Oncology. Chicago, IL, US.
- 2009. Supportive care. Conference. APAO. Tampa, FL, US.
- 2009. Supportive care. Conference. Association of Physician Assistants in Oncology (APAO). Boston, MA, US.
- 2009. E3Z02 study. Conference. ECOG. Philadelphia, PA, US.
- 2009. New perspectives in symptom management for ambulatory patients with advanced malignancy. Conference. Raleigh County Medical Society, Inc. Beckley, WV, US.
- 2009. Assessment and management of chronic pain in a cancer patient. Conference. Continuing Medical Education. Albuquerque, NM, US.
- 2009. Supportive care update. Conference. Cancer Clinics if Excellence. Boston, MA, US.
- 2009. Symptom task force: Neuropathy. Conference. NCI. Rockville, MD, US.
- 2008. Psychosocial issues. Conference. Johns Hopkins Bloomberg School of Public Health. Baltimore, MD, US.
- 2008. Chronic symptom care. Conference. CCE. New Orleans, LA, US.
- 2003. Methadone for outpatients with severe pain and chronic illness. Conference. Hospice El Paso. El Paso, TX, US.
- 2002. Pearls and paradigms in pain and symptom management for patients with advanced illness. Conference. Hospice Brazos Valley. Bryan, TX, US.
- 2002. New developments in pain medicine. Conference. Hospice of Brazos Valley, Brenham. Brenham, TX, US.
- 2002. Integrating palliative care with aggressive cancer care. Conference. UT M.D. Anderson Cancer Center, US.
National Presentations
- 2019. Prior Approval in Cancer Care: The Good, The Bad, and The Ugly. Invited. Michigan Society of Hematology/Oncology Fall 2019 Meeting. Mackinaw Island, MI, US.
- 2019. High cost claims and evolving solutions in the realm of cancer care. Invited. BCS Financial Fall Meeting. Chicago, IL, US.
- 2019. Improving Quality and Affordability of Cancer Care. Invited. Innovations in Cancer Care: Blue Cross Blue Shield 2019 National Summit. Grapevine, TX, US.
- 2019. Innovation in Cancer Care: Driving quality and value. Invited. Blue Cross Blue Shield Association National Summit 2019,. Grapevine, TX, US.
- 2018. Rallying Oncologists to Social Media for Clinical Trials. Invited. NIH Conference. Bethesda, MD, US.
- 2014. Teaching critical thinking and digital literacy to solve real problems. Invited. Jennifer Salopk, AAMC. Chicago, IL, US.
- 2014. Patient-centered care across the cancer continuum. Invited. American Society of Clinical Oncologists (ASCO). Boston, MA, US.
- 2014. Early integration of palliative and supportive care in the cancer continuum. Invited. Nebraska Oncology Society Annual Meeting. Omaha, NE, US.
- 2013. Steps toward achieving synergy between cardiology and oncology. Invited. ECOG-ACRIN Spring Group Meeting. Atlanta, GA, US.
- 2013. How SWOG can make use of social media: Harnessing the power of engagement. Invited. Southwest Oncology Group (SWOG). San Francisco, CA, US.
- 2013. What should cardiology and oncology's practice goals be to achieve synergy?. Invited. Community Oncology. Las Vegas, NV, US.
- 2012. Disparities in cancer palliative care for medically underserved populations. Invited. The Science of Cancer Health Disparities. San Diego, CA, US.
- 2012. Co-morbidities and cancer. Invited. 8th Annual Supportive Oncology Conference. Chicago, IL, US.
- 2005. Pearls and paradigms in the palliative care of cancer patients. Invited. 16th Annual Cancer Update Conference. San Antonio, TX, US.
- 2005. Confessions of an oncologist turned palliative care specialist. Invited. Vanderbilt-Ingram Cancer Center Seminar. Nashville, TN, US.
- 2004. Methadone use in hospice and palliative care settings. Invited. National Hospice and Palliative Care Organization Virtual Audio Conference, US.
- 2004. Recognition and treatment of depression in cancer patients. Conference. UTMDACC, US.
- 2003. Pain management in the cancer patient. Invited. 6th Annual Meeting of the Association of Physician Assistants in Oncology. Austin, TX, US.
- 2003. National clinical trials of new agents for symptom control. Conference. UTMDACC, US.
- 2003. Methadone use in the hospice setting: Safe, effective and cost-efficient. Invited. 4th Joint Clinical Conference on Hospice and Palliative Care. Denver, CO, US.
- 2003. Symptom management and palliative care. Invited. American Academy of Pain Medicine 19th Annual Meeting. New Orelans, LA, US.
- 2002. Treatment of depression. Invited. Natcher Conference Center. Bethesda, MD, US.
- 2002. Treatment of depression in cancer patients. Invited. Einhorn Symposium. Indianapolis, IN, US.
- 2002. Methadone use in the hospice setting: Safe, effective, and cost-efficient. Invited. The Texas and New Mexico State Hospice Meetings of the National Hospice Organization. Houston, TX, US.
- 2002. Pearls and paradigms in palliative care. Conference. UTMDACC, US.
- 2002. End of life issues for cancer patients. Invited. 2nd Annual Oncology Update: Advances and Controversies. Steamboat, CO, US.
- 2001. Pain and supportive care. Invited. Fourth Annual Meeting of the Association of Physician Assistants in Oncology. Houston, TX, US.
- 2001. Treatment of nausea and vomiting. Invited. Hoosier Oncology Group Spring Meeting. Indianapolis, IN, US.
- 2000. Integrated models of palliative care: An oncologist’s perspective future end-of-life care: Best ideas, practices, policies. Invited. W.K. Kellogg Foundation National Leadership Program Seminar. Warrenton, VA, US.
- 2000. Palliative care issues in Latin America. Invited. 12th Annual Assembly. Atlanta, GA, US.
- 2000. Hospice care. Conference. UTMDACC, US.
- 2000. Recognition and management of depressive symptoms in advanced cancer outpatients. Invited. Hoag Cancer Center 2000 Winter Symposia. Newport Beach, CA, US.
- 2000. The role of palliative care. Invited. Technology Futures Panel on Oncology Premier, Inc. St. Petersburg, FL, US.
International Presentations
- 2020. Association between a national insurer’s pay-for-performance program for oncology and changes in prescribing of evidence-based cancer drugs and spending. Invited. J Clin Oncol, US.
- 2019. The use of optimal evidence-based chemotherapy regimens in physician offices versus hospital outpatient facilities. Invited. ASCO Annual Meeting. Chicago, US.
- 2019. Reproductive health in cancer. Invited. ASCO Annual Meeting. Chicago, US.
- 2019. Reimbursement methodologies in support of precision medicine. Invited. Precision Medicine World Conference. Santa Clara, US.
- 2019. The use of optimal evidence-based chemotherapy (chemo) regimens in physician offices versus hospital outpatient facilities. Invited. ASCO Annual Meeting. Chicago, US.
- 2018. Avoiding Mistakes that Faculty Didn’t. Invited. American Society of Clinical Oncology (ASCO). Sydney, AU.
- 2018. Use of Social Media for Clinical Trials. Invited. American Society of Clinical Oncology (ASCO). Sydney, AU.
- 2018. Supportive care (SxSC) trials. Invited. American Society of Clinical Oncology (ASCO). Sydney, AU.
- 2018. Occurrence and characteristics of hospitalizations during first-line chemotherapy among individuals with metastatic colorectal cancer. Invited. ASCO Gastrointestinal Cancer Symposium. San Francisco, US.
- 2016. Use of Social Media in Oncology Practice. Invited. American Society of Clinical Oncology (ASCO). Chicago, US.
- 2014. Symptom management and supportive care (SxSC) trials. Invited. American Society of Clinical Oncology (ASCO). Sydney, AU.
- 2014. Guidelines for appropriate use of social media and social networking in medical practice. Invited. Annual Meeting of the American Society of Clinical Oncology (ASCO). Chicago, US.
- 2014. Introduction to the NCI Community Oncology Research Program (NCORP): What does it mean to cardio oncology?. Invited. Canadian Cardiac Oncology Network. Ottawa, CA.
- 2013. New research into sleep disturbances, treatment related toxicities and psychosocial issues of cancer. Invited. Annual Meeting of the American Society of Clinical Oncology. Chicago, US.
- 2012. What should cardiology and oncology's practice goals be to achieve synergy?. Invited. International CardiOncology Society Annual Meeting. Milan, IT.
- 2012. Determinants of fatigue improvement in outpatient oncology according to baseline categories of fatigue severity. Invited. Annual Meeting of the American Society of Clinical Oncology (ASCO). Chicago, US.
- 2005. Assessing and teaching humanistic and spiritual aspects of cancer care. Invited. Annual Meeting of the American Society of Clinical Oncology, US.
- 2004. Depression in patients with cancer: diagnosis and treatment considerations. Invited. Annual Meeting of the American Society of Clinical Oncology, US.
- 2003. Palliative care: The M. D. Anderson experience. Invited. COMDAIE Oncology Symposium. Madrid, ES.
- 2002. Public policy and the impact on oncology. Invited. 38th ASCO Annual Meeting. Orlando, US.
Formal Peers
- 2016. Large database research in supportive oncology. Invited. Massachusetts General Hospital. Boston, MA, US.
- 2015. Large database research in supportive oncology. Invited. Massachusetts General Hospital. Boston, MA, US.
- 2014. Understanding the symptom experience in outpatients with common solid tumors...and what you can do to improve care. Invited. Winship Cancer Institute of Emory University. Atlanta, GA, US.
- 2013. Integrating palliative care into oncology care at game speed: Challenges and opportunities. Invited. Jefferson University. Philadelphia, PA, US.
- 2012. Palliative Care. Visiting. ASCO. Accra, GH.
- 2012. Understanding the symptom experience in outpatients with common solid tumors...and what you can do to improve care. Invited. Siteman Cancer Center. St. Louis, MO, US.
- 2011. Palliative Care. Visiting. ASCO. Accra & Kumasi, GH.
- 2010. How to Improve Cancer Care in the Arab World. Visiting. King Saud Bin Abdulaziz University - Visiting Professor Program. Riydah, SA.
- 2005. Palliative care in a comprehensive cancer center: The M.D. Anderson experience. Invited. VA San Diego Healthcare System Grand Rounds. San Diego, CA, US.
- 2005. Oncology Fellows’ Noon Conference. Invited. Oncology Fellows’ Noon Conference, US.
- 2005. Schwartz Rounds series. Invited. Schwartz Rounds series, US.
- 2004. Cooperative Group Research. Invited. Cooperative Group Research, US.
- 2004. Symptom Management. Invited. Lyndon B. Johnson General Hospital, US.
- 2004. The role of methadone in the management of pain in outpatients with cancer. Invited. Ireland Cancer Center of Case Western Reserve Univ. Cleveland, OH, US.
- 2004. Education for End-of-Life Care. Invited. Oncology (EPEC-O), US.
- 2003. Pearls and paradigms in the palliation of patients with gynecologic malignancy. Invited. Mayo Clinic. Rochester, MN, US.
- 2003. Pain/Supportive Care. Invited. MDACC, US.
- 2002. Fatigue and anemia in advanced cancer patients. Invited. Indiana University. Indianapolis, IN, US.
- 2002. Managing fatigue in outpatients with chronic illness: Pearls, paradigms and minimal data. Invited. John Hopkins University, US.
- 2002. Recognition and management of depression in advanced cancer outpatients. Invited. Siteman Cancer Center, Washington University. St. Louis, MO, US.
- 2002. Palliative Care Pearls and Paradigms. Invited. Palliative Care Pearls and Paradigms. Salem, VA, US.
- 2002. Pain/Supportive Care. Invited. MDACC, US.
- 2001. Recognition and management of depression in advanced cancer outpatients. Invited. Massey Cancer Center, Medical College of Virginia. Richmond, VA, US.
- 2001. Tricks of the Trade in Palliative Care. Invited. Brochstein Conference Room, US.
- 2001. Pain/Supportive Care. Invited. MDACC, US.
- 2000. Depression & Anxiety in Cancer Patients. Invited. UT/Houston, US.
- 2000. Depression/Anxiety/Delirium. Invited. R11 Conference Rooms, US.
- 2000. Pain/Supportive Care. Invited. MDACC, US.
- 2000. End of Life Care and Pain Management Course. Invited. UT/Houston, US.
- 1997. Student Cancer Day. Invited. University of Virginia, US.
- 1997. Introduction to Clinical Medicine. Invited. University of Virginia, US.
Grant & Contract Support
| Date: | 2019 - 2024 |
| Title: | SWOG NCORP Research Base |
| Funding Source: | Department of Health and Human Services |
| Role: | PI |
| ID: | 5UG1CA189974-10 |
| Date: | 2014 - 2019 |
| Title: | Caragiver Self-Efficacy and Therapeutic Alliance in End of Life Cancer Care |
| Funding Source: | NIH/NCI |
| Role: | Principal Investigator-MDACC |
| Date: | 2014 - 2019 |
| Title: | NCI Community Oncology Reseach Program(NCORP) Research Base (UM1) |
| Funding Source: | NIH/NCI |
| Role: | PI |
| Date: | 2014 - 2019 |
| Title: | ECOG-ACRIN NCORP Research Base |
| Funding Source: | Ecog-ACRIN Medical Research Foundation |
| Role: | PI |
| Date: | 2014 - 2019 |
| Title: | A Randomized Dissemination Trial to Improve Sexual Outcomes in Men with Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Date: | 2014 - 2017 |
| Title: | Adaptive Trial of Web Intervention for Cancer-Related Female Sexual Problems |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Date: | 2014 - 2019 |
| Title: | Patient-Centered Outcomes: Knowledge Generation, Synthesis and Translation |
| Funding Source: | AHRQ |
| Role: | Mentor |
| ID: | 1K12HS023005-01 |
| Date: | 2014 - 2019 |
| Title: | CYCORE: Cyberinfrastructure for Cancer Comparative Effectiveness Research |
| Funding Source: | NIH/NCI |
| Role: | Significant Contributor |
| Date: | 2014 - 2019 |
| Title: | UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1 U10 CA180858-01 |
| Date: | 2013 - 2018 |
| Title: | Workshop on Methods in Supportive Oncology Research |
| Funding Source: | NIH/NCI |
| Role: | Consult |
| Date: | 2013 - 2016 |
| Title: | Preventing dehydration in irradiated cancer patients: A comparative effectiveness study |
| Funding Source: | Patient-Centered Outcomes Research Institute (PCORI) |
| Role: | N/A |
| Date: | 2013 - 2016 |
| Title: | Presenting Patient-Reported Outcomes Data to Improve Patient and Clinician Understanding and Use |
| Funding Source: | Patient-Centered Outcomes Research Institute |
| Role: | Stakeholder Advisor |
| Date: | 2013 - 2014 |
| Title: | Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1R21 CA167202-01A1 |
| Date: | 2012 - 2015 |
| Title: | Improved Management of Bloodstream HAI with Antimicrobial Catheter Lock Solution |
| Funding Source: | Agency for Health Care Research and Quality (AHRQ) |
| Role: | Co-I |
| ID: | R18 HS019985 |
| Date: | 2012 - 2015 |
| Title: | ECOG CCOP Research Base |
| Funding Source: | NIH/NCI through Frontier Science and Technology Research Foundation, Inc |
| Role: | PI |
| ID: | 2 U10 CA037403-27 |
| Date: | 2012 - 2014 |
| Title: | Integrating technology and navigation to improve survivorship care in underserved populations |
| Funding Source: | MD Anderson Cancer Survivorship Research Seed Money Grant |
| Role: | Co-I |
| ID: | IRG MDACC |
| Date: | 2011 - 2012 |
| Title: | ECOG and ACRIN Consolidation |
| Funding Source: | ECOG-CCOP |
| Role: | PI |
| ID: | 3U10CA086802-13S1 |
| Date: | 2010 - 2015 |
| Title: | A Phase I Study of Sublingual Anvirzel (Nerium oleander) in Advanced Non-Small Cell Lung Cancer |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | U10 CA045809-25 (Suppl) Carryover |
| Date: | 2010 - 2013 |
| Title: | SOAPP (Symptom Outcomes and Practice Patterns): A Survey of Disease and Treatment-Related Symptoms in Patients with Invasive Cancer of the Breast, Prostate, Lung or Colon/Rectum |
| Funding Source: | NIH/NCI through Frontier Science and Technology Research Foundation, Inc |
| Role: | PI |
| Date: | 2010 - 2011 |
| Title: | CYCORE: CYberinfrastructure for COmparative Effectiveness REsearch |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | RC2 CA148263-01 |
| Date: | 2009 - 2013 |
| Title: | Monoclonal Antibodies in Cancer Care: Is Underinsurance An Access Barrier? |
| Funding Source: | NIH/AHRQ |
| Role: | Investigator |
| ID: | 1 R01 HS018535 01 |
| Date: | 2009 - 2015 |
| Title: | Adherence to Swallowing Rehabilitation Exercises in Head and Neck Center |
| Funding Source: | NIH/NIDCR |
| Role: | Significant Contributor |
| ID: | 5 R01 DE01914-04 |
| Date: | 2008 - 2013 |
| Title: | A Multicenter Study to Assess the Detection of Cardiotoxicity Using Biomarkers and Prevent Left Ventricular Dysfunction |
| Funding Source: | Alere |
| Role: | PI |
| ID: | CS2008-00021927JW |
| Date: | 2008 - 2010 |
| Title: | Identification and Treatment of Depression in Underserved African American and Latino Patients with Cancer |
| Funding Source: | Robert Wood Johnson Foundation |
| Role: | Co-I |
| ID: | 64272 |
| Date: | 2008 - 2013 |
| Title: | Randomized, Double-Blind, Placebo-Controlled Trial of Palonosetron/Dexamethasone with or without Droabinol for the Prevention of Chemotherapy-induced Nausea and Vomiting after Moderately Emetogenic Chemotherapy |
| Funding Source: | Solvay Pharmaceuticals |
| Role: | Co-PI |
| ID: | CS2008-000222929JW |
| Date: | 1999 - 2001 |
| Title: | A phase II study of the combination of bepridil plus stelazine for prostate cancer |
| Funding Source: | Cancer Treatment Research Foundation |
| Role: | NA |
| Date: | 1997 - 1998 |
| Title: | The prevalence and significance of depression in cancer outpatients |
| Funding Source: | American Cancer Society |
| Role: | NA |
| ID: | 91918 |
| Date: | 1996 - 2015 |
| Title: | The University of Texas MD Anderson Cancer Center Community Clinical Oncology Program Research Base |
| Funding Source: | National Cancer Institute |
| Role: | PI |
| ID: | 5 U10 CA045809-25 |
| Date: | 1996 - 2015 |
| Title: | MD Anderson Echo supplement |
| Funding Source: | NIH/NCI |
| Role: | Principal Investigator-MDACC |
| ID: | 5U10CA045809-25 REVISED Suppl |
| Date: | 1996 - 1997 |
| Title: | The use of an electronic medical record to examine practice patterns |
| Funding Source: | Walther Cancer Institute |
| Role: | NA |
| Date: | 1994 - 1995 |
| Title: | Informed Consent in Adult Autologous Bone Marrow Transplant Patients |
| Funding Source: | Walther Cancer Institute |
| Role: | NA |
| Date: | 1986 - 2014 |
| Title: | Reducing the Symptom Burden Produced by Aggressive Cancer Therapies |
| Funding Source: | National Cancer Institute |
| Role: | Co-I |
| ID: | 2 R01 CA026582 31 A1 |
| Title: | Using Geriatric Methods to prospectively evaluate the fall risk in older cancer patients treated with chemotherapy in an urban county hospital |
| Funding Source: | UTMDACC Cancer Survivorship Research Seed Money Grant |
| Role: | Collaborator |
| ID: | N/A |
Patient Reviews
CV information above last modified April 16, 2025